- Stocks
- Capital Goods
- Hemo Organic
Hemo Organic share price
NSE: HEMORGANICCapital GoodsConglomerates
Hemo Organic at a glance
With a market capitalisation of ₹7 Cr, it ranks 3993rd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Capital Goods sector; its industry is Conglomerates.
Its return on equity was −108.2% in FY25.
Key numbers
- Market cap
- ₹7 CrRank 3993 on NSE
- Price to book
- -20.53×FY25
- ROE
- −108.2%FY25
- ROCE
- 1.9%FY25
- Debt to equity
- -9.77FY25
- Net profit margin
- 6.8%FY25
- Book value / share
- −₹0.44FY25
Returns to 19 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Hemo Organic financials
| Item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr |
| Operating profit | −₹0 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr | ₹0 Cr |
| Net profit | −₹0 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr | ₹0 Cr |
| EPS (₹) | −₹0.01 | −₹0.14 | −₹0.18 | −₹0.16 | −₹0.76 | ₹0.47 |
| Cash from operations | ₹0 Cr | −₹0 Cr | ₹0 Cr | ₹0 Cr | −₹1 Cr | −₹0 Cr |
| Total debt | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Shareholders' equity | ₹0 Cr | ₹0 Cr | ₹0 Cr | −₹0 Cr | −₹0 Cr | −₹0 Cr |
Hemo Organic vs peers
The listed Capital Goods companies nearest to Hemo Organic by market capitalisation.
Ask anything about Hemo Organic
Pivot answers on the live chart with evidence you can check, and tests strategies against HEMORGANIC's own history. Try: “Why has HEMORGANIC moved over the last three months?” · “Backtest a 50-day moving-average crossover on HEMORGANIC over five years” · “Compare HEMORGANIC with JONJUA on margins and valuation”
Frequently asked questions about Hemo Organic
What is the market cap of Hemo Organic?
Hemo Organic's market capitalisation is ₹7 Cr (₹7 Cr) at the 19 Oct 2026 close, ranking 3993rd among the NSE companies Pivot tracks.
What is the ROE and ROCE of Hemo Organic?
Return on equity was −108.2% in FY25 and return on capital employed was 1.9% in FY25 (standalone figures).
Is Hemo Organic a debt-free company?
Hemo Organic is close to debt-free: its debt-to-equity ratio was -9.77 in FY25.
Who are Hemo Organic's competitors?
The listed Capital Goods companies closest to Hemo Organic by market cap are Jonjua Overseas, Harig Crankshaf, Premier, Incon Engineers, Parker Agro and Amraworld.
Is Hemo Organic a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Hemo Organic's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on HEMORGANIC against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 19 Oct 2026 (returns and ratios at the 19 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Capital Goods stocks · companies starting with H · all NSE stocks · this page as text